316 related articles for article (PubMed ID: 25071906)
1. Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma according to Helicobacter pylori infection status: a single-center experience.
Ryu KD; Kim GH; Park SO; Lee KJ; Moon JY; Jeon HK; Baek DH; Lee BE; Song GA
Gut Liver; 2014 Jul; 8(4):408-14. PubMed ID: 25071906
[TBL] [Abstract][Full Text] [Related]
2. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
Al-Taie O; Al-Taie E; Fischbach W
Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori.
Nakamura S; Matsumoto T; Suekane H; Takeshita M; Hizawa K; Kawasaki M; Yao T; Tsuneyoshi M; Iida M; Fujishima M
Gut; 2001 Apr; 48(4):454-60. PubMed ID: 11247887
[TBL] [Abstract][Full Text] [Related]
5. [Clinical Efficacy of Radiotherapy in
Park BS; Lee SH
Korean J Gastroenterol; 2019 Jan; 73(1):19-25. PubMed ID: 30690954
[TBL] [Abstract][Full Text] [Related]
6. [Helicobacter pylori eradication for stage I(E₁) gastric mucosa-associated lymphoid tissue lymphoma: predictive factors of complete remission].
Kim SJ; Yang S; Min BH; Lee JH; Rhee PL; Rhee JC; Kim JJ
Korean J Gastroenterol; 2010 Feb; 55(2):94-9. PubMed ID: 20168055
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
Kuo SH; Cheng AL
Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma.
Park JB; Koo JS
World J Gastroenterol; 2014 Mar; 20(11):2751-9. PubMed ID: 24659867
[TBL] [Abstract][Full Text] [Related]
9. [Gastric Mucosa-associated Lymphoid Tissue Lymphoma Based on Outcome of Domestic Treatment].
Jung JT
Korean J Gastroenterol; 2016 Oct; 68(4):175-178. PubMed ID: 27780940
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Alpen B; Röbbecke J; Wündisch T; Stolte M; Neubauer A
Ann Hematol; 2001; 80 Suppl 3():B106-7. PubMed ID: 11757689
[TBL] [Abstract][Full Text] [Related]
11. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
13. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
[TBL] [Abstract][Full Text] [Related]
14. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
16. What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma?
Thiede C; Morgner A; Alpen B; Wündisch T; Herrmann J; Ritter M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A
Gastroenterology; 1997 Dec; 113(6 Suppl):S61-4. PubMed ID: 9394762
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
[TBL] [Abstract][Full Text] [Related]
18. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.
Montalban C; Santon A; Boixeda D; Bellas C
Gut; 2001 Oct; 49(4):584-7. PubMed ID: 11559658
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma.
Park HS; Kim YJ; Yang WI; Suh CO; Lee YC
World J Gastroenterol; 2010 May; 16(17):2158-62. PubMed ID: 20440857
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
